¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"membrane glycoprotein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® arachnoid membrane ÇÑ±Û °Å¹Ì¸·
¼³¸í   
  ³ú¸·À» ÀÌ·ç´Â ¸·ÀÇ Çϳª. ³ú¸·À̶õ ³ú¸¦ ½Î°í Àִ ¸·À¸·Î Å©°Ô 3°³ÀÇ ¸·À¸·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. °¡Àå¹Ù±ù¿¡ Àִ ¸·À» °æÁú¸·(dura mater)À̶ó°í ÇÑ´Ù. ±× ´ÙÀ½ÀÇ ¸·ÀÌ °Å¹Ì¸·ÀÌ´Ù. ±×¸®°í ³ú¿¡ °­ÇϰԠ¹ÐÂøµÇ¾î Àִ °¡Àå ¾ÈÂÊÀÇ ¸·ÀÌ ¿¬¸·(pia mater)ÀÌ´Ù. °Å¹Ì¸·Àº ¿¬¸·°ú °Å¹ÌÁÙ°°Àº ±¸Á¶¹°·Î ¾ÆÁÖ ´À½¼ÇϰԠºÎÂøµÇ¾î ÀÖ´Ù. ±×·¡¼­ °Å¹Ì¸· ¹Ø¿¡´Â °ø°£ÀÌ ÀÖ´Ù. ÀÌ °ø°£À» °Å¹Ì¸·¹Ø°ø°­À̶ó°í Çϰí ÀÌ °ø°£Àº ¸¼Àº ¾×ü·Î Â÷ ÀÖ´Ù. ÀÌ ¾×ü¸¦ ³úô¼ö¾×(cerebrospinal fluid)À̶ó°í ÇÑ´Ù.
  
  °Å¹Ì¸·
  
  
¿µ¹® basement membrane ÇÑ±Û ¹Ù´Ú¸·, ±âÀú¸·
¼³¸í   
  »óÇǼ¼Æ÷, ±ÙÀ°¼¼Æ÷, ½Å°æÁ¶Á÷°ú ±×°ÍµéÀÇ ¹Ù±ùÂÊ °áÇÕÁ¶Á÷ÀÇ °æ°è¿¡ Àִ Á¡¾×´Ù´çÁú°ú ´Ü¹éÁú·Î ±¸¼ºµÈ ¾ãÀº ¸·. ±âÃʸ· ¶Ç´Â °æ°è¸·À̶ó°íµµ ÇÑ´Ù. µÎ²²´Â 50~80nmÀÌ´Ù. ±âÀú¸·Àº 20~30nm °£°ÝÀ¸·Î ´Ã¾î¼± Á·¼¼Æ÷·Î µÈ »óÇǼ¼Æ÷ÀÇ 3ÃþÀ¸·Î µÇ¾î ÀÖ°í, ºÐÀÚ·® 40,000~60,000ÀÇ ¹°ÁúÀ» Åõ°úÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. ¶ÇÇѠǥÇǿ͠ÁøÇÇÀÇ °æ°è·Î ¿µ¾çÀ» °ø±ÞÇϴ ±âÁö ¿ªÇÒÀ» ÇÑ´Ù. ÁַΠ¼¶À¯¸¦ Æ÷ÇÔÇÏ¿© ´Ù´ç·ù·Î µÇ¾î Àִµ¥, ÇöÀúÇϰԠ¹ß´ÞµÇ¾î Àִ ºÎºÐ°ú ±×·¸Áö ¾ÊÀº ºÎºÐÀÌ ÀÖ´Ù. ºñÁ¡¸·¿¡¼­´Â Á¡¸·»óÇÇÀÇ ¹Ø¿¡ ¹ß´ÞÇÑ ±âÀú¸·ÀÌ ÀÖ´Ù. ÀÌ ¸· À§¿¡ Ã»°¢¼ö¿ë¼¼Æ÷ÀΠÅм¼Æ÷¸¦ °®´Â ÄÚ¸£Æ¼±â°üÀÌ Á¸ÀçÇÑ´Ù. ±âÀú¸·Àº ÀüÁ¦°¡ À½Àü±â ¼ºÁúÀ» °¡Áö°í À־çÀü±â¸¦ °¡Áø ¹°ÁúÀÌ Åõ°úÇϱ⠽±´Ù. ±âÀú¸·ÀÌ ÆØÈ­Çϰųª ¹Ðµµ°¡ ³·¾ÆÁö¸é ´Ü¹éÁúÀÌ Åë°úÇÏ¿© ´Ü¹é´¢¸¦ ÀÏÀ¸Å°°í, ±âÀú¸·¿¡ ±Õ¿­-ÆÄ±« µîÀÌ ÀϾ¸é ÀûÇ÷±¸ µîÀÇ Ç÷¾× °íÇü¼ººÐÀÌ Åõ°úÇÏ¿© Ç÷´¢°¡ µÈ´Ù.
¿µ¹® hyaline membrane disease ÇÑ±Û À¯¸®Áú¸·º´
¼³¸í   
  ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½Ã۴ ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼­ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼­´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀΠº´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ­, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êȭź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. È¯¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú Ã·´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼­ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈĴ Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־´Â Ä¡·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù.
¿µ¹® plasma membrane ÇÑ±Û ÇüÁú¸·
¼³¸í   
  ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀǠǥ¸é È°¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿­µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼­ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯Çϸ頱נÅõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • variant surface glycoprotein
    »óÀÌÇ¥¸é´ç´Ü¹éÁú
  • arachnoid membrane
    °Å¹Ì¸·, ÁöÁÖ¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·, ȯÃßÈĵθ·
  • acrosomal membrane
    ÷´Üü¸·
  • alveolar-capillary membrane
    ÆóÆ÷¸ð¼¼Ç÷°ü¸·, ÇãÆÄ²Ê¸®¸ð¼¼Ç÷°ü¸·
  • amnionic membrane
    ¾ç¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • basilar membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • buccopharyngeal membrane
    º¼Àεθ·
  • cloacal membrane
    ¹è¼³°­¸·
  • cricothyroid membrane
    ¹ÝÁö¹æÆÐ¸·, À±»ó°©»ó¸·
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • thin basement membrane disease
    ¾ãÀº¹Ù´Ú¸·º´, ¾ãÀº±âÀú¸·º´
  • membrane
    ¸·
  • amnionic membrane
    ¾ç¸·
  • arachnoid membrane
    °Å¹Ì¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • mucous membrane
    Á¡¸·
  • nuclear membrane
    ÇÙ¸·
  • periorbital membrane
    (¢¡ periorbita) ´«È®»À¸·, ¾È¿Í°ñ¸·
  • plasma membrane
    ÇüÁú¸·
  • semipermeable membrane
    ¹ÝÅõ¸·
  • serous membrane
    À帷
  • slit membrane
    Æ´»õ¸·
  • spiral membrane
    ³ª¼±¸·, °í½Ç°è´Üº®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • variant surface glycoprotein
    »óÀÌÇ¥¸é´ç´Ü¹éÁú
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·
  • arachnoid membrane
    °Å¹Ì¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • buccopharyngeal membrane
    º¼Àεθ·
  • membrane bone
    ¸·»À
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • reticulofibrous membrane bone
    (¢¡primary membrane bone) ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
  • chorioallantoic membrane
    À¶¸ð¸·¿ä¸·
  • choriocapillary membrane
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycoprotein hormones, ligands
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)È£¸£¸ó, ¸®°£µå
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ).
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • platelet glycoprotein
    Ç÷¼ÒÆÇ´ç´Ü¹é
  • Barkan membrane
    ¹Ù¸£Ä­¸·
  • Bowmans membrane
    º¸¿ì¸¸¸·
  • Descemets membrane
    µ¥½º¸Þ¸·.
  • EBV membrane antigen
    EB¹ÙÀÌ·¯½º ¸·Ç׿ø
  • EBV membrane antigen (MA)
    EB¹ÙÀÌ·¯½º ¸·Ç׿ø
  • Glomerular membrane
    »ç±¸Ã¼¸·(¡­Ø¯)
  • Golgi s membrane
    °ñÁö¸·.
  • Hyaline membrane disease
    À¯¸®Áú¸·º´(ë¤×ãòõدܻ)
  • Integral membrane protein
    ÅëÇÕ(÷Öùê) ¸·´Ü¹é(Ø­Ó±ÛÜ)
  • Lysosomal membrane
    ¶óÀ̼Ҽظ·(¡­Ø­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membrane glycoprotein
    ¸·´ç´Ü¹é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • a-glycoprotein
  • alpha1-acid glycoprotein
    ¾ËÆÄ-»ê´ç´Ü¹é
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ).
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • platelet glycoprotein
    Ç÷¼ÒÆÇ´ç´Ü¹é
  • surface glycoprotein
    Ç¥¸é´ç´Ü¹é(Áú)(øúØüÓØÓ±ÛÜ)
  • oropharyngeal membrane [buccopharyngeal membrane]
    ÀÔÀεθ·
  • vestibular wall [vestibular membrane, reissners membrane]
    ¾È¶ã°è´Üº® [¾È¶ã¸·]
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·.
  • anal membrane
    Ç×¹®¸·
  • antebrachial interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Vestibular wall [Vestibular membrane Reissner`s membrane]
    ¾È¶ã°è´Üº® [¾È¶ã¸·]
    [¿¾ ¿ë¾î] ÀüÁ¤º®[¸·]
  • Oropharyngeal membrane [Buccopharyngeal membrane]
    ÀÔÀεθ·
    [¿¾ ¿ë¾î] ±¸°­Àεθ·
  • (Pupillary membrane)
    (µ¿°ø¸·)
    [¿¾ ¿ë¾î] µ¿°ø¸·
  • Pleuroperitoneal membrane
    °¡½¿¸·º¹¸·¸·
    [¿¾ ¿ë¾î] È丷½É¸·¸·
  • Pleuropericardial membrane
    °¡½¿¸·½ÉÀ帷¸·
    [¿¾ ¿ë¾î] È丷½É¸·¸·
  • Suprapleural membrane
    °¡½¿¸·À§¸·
    [¿¾ ¿ë¾î] È丷»ó¸·
  • Syndesmochorial membrane
    °áÇÕÁ¶Á÷À¶¸ð¸·
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷À¶¸ð¸·¼ºÇ÷°£°³À縷
  • Limiting membrane
    °æ°è¸·
    [¿¾ ¿ë¾î] °æ°è¸·
  • Tympanic membrane
    °í¸·
    [¿¾ ¿ë¾î] °í¸·
  • Tympanic membrane
    °í¸· [±Íû]
    [¿¾ ¿ë¾î] °í¸·
  • Tympanic membrane
    °í¸· [±Íû]
    [¿¾ ¿ë¾î] °í¸·º®
  • Branches to tympanic membrane
    °í¸·°¡Áö
    [¿¾ ¿ë¾î] °í¸·Áö
  • Umbo of tympanic membrane
    °í¸·¹è²Å
    [¿¾ ¿ë¾î] °í¸·Á¦
  • Recesses of tympanic membrane
    °í¸·¿À¸ñ
    [¿¾ ¿ë¾î] °í¸·ÇÔ¿ä
  • Tympanic wall [Spiral membrane]
    °í½Ç°è´Üº® [³ª¼±¸·]
    [¿¾ ¿ë¾î] °í½Çº®
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable surface glycoprotein (VSG)
    º¯À̼ºÇ¥¸é´ç´Ü¹éÁú
  • egg membrane
    ³­¸·
  • embryonic membrane
    ÀÚÃæ¸·
  • outer embryophore membrane
    Á¶Ãæ¶õ¿Ü¸·
  • undulating membrane
    ÆÄµ¿¸·
  • vitelline membrane
    ³­È²¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • Tamm-Horsfall glycoprotein
    Ž-È£¸£½ºÆú ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • bare lipid membrane
    ¾Ë¸ö ÁöÁú¸·(ò·òõد)
  • bilayer lipid membrane
    ¾çÃþ ÁöÁú¸·(å»öµ ò·òõد)
  • bileaflet membrane
    ÀÌÁß¼Ò¿±¸·(ì£ñìá³ç¨Ø¯)
  • bimolecular lamellar lipid membrane
    À̺ÐÀÚ(ì£ÝÂí­) ÆÇ»óÁöÁú¸·(÷ùßÒò·òõد)
  • bimolecular lipid membrane
    À̺ÐÀÚ ÁöÁú¸·(ì£ÝÂí­ò·òõد)
  • black lipid membrane
    Èæ ÁöÁú¸·(ýÙò·òõد)
  • cell membrane
    ¼¼Æ÷¸· (á¬øàØ¯)
  • cytoplasmic membrane
    "¼¼Æ÷Áú ¸·(á¬øàòõد), (ÔÒ) cell membrane"
  • inner membrane
    ³»¸·(Үد)
  • inner membrane particle
    ³»¸·ÀÔÀÚ(Үدأí­)
  • inner membrane sphere
    ³»¸·±¸(ҮدϹ)
  • membrane carrier
    ¸·¿î¹Ýü(دê¡Úæô÷)
  • membrane equilibrium
    ¸·ÆòÇü(دøÁû¬)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹éÁú
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • membrane
    ¸·
  • mucous membrane
    Á¡¸·
  • periorbital membrane
    ¾È¿Í°ñ¸·
  • serous membrane
    À帷
  • synovial membrane
    À±È°¸·, Ȱ¸·
  • tympanic membrane
    °í¸·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SCM Schwann cell membrane; sensation, circulation, and motion; Society of Computer Medicine; soluble cyt...
SGP serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein...
PROM   1) Premature Rupture of Amniotic Membrane; < Labor Onset
  2) Preterm Ruptu...
BLM bilayer lipid membrane; bimolecular liquid membrane; bleomycin; buccolinguomasticatory
BM Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGP 1-Acid glycoprotein
GP 2-glycoprotein
GP I glycoprotein I
PAG 2-pregnancy-associated glycoprotein
AEG Acidic epididymal glycoprotein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antibasement membrane antibody
    Ç×±âÀú¸· Ç×ü
  • arachnoid membrane
    °Å¹Ì¸·
    ³ú¿Í ô¼ö¸¦ µÑ·¯½Ñ ¼¼ ÃþÀÇ ¸· Áß Áß°£Ãþ.
  • autoantibody against basement membrane
    Ç×±âÀú¸· ÀÚ°¡ Ç×ü
  • basal membrane of semicircular canal
    ¹Ý±Ô°ü ±âÀú¸·, ¹Ý°í¸®°ü ¹Ù´Ú ¸·
  • basilar membrane
    ±âÀú ¸·
  • benign mucous membrane pemphigoid
    ¾ç¼º Á¡¸· À¯ÃµÆ÷â
  • biological membrane
    »ýü ¸·
    ¼¼Æ÷ ¶Ç´Â ¼¼Æ÷ ¼Ò±â°üÀÇ °ÑÀ» ½Î°í ÀÖ´Â ¸·. ¹Ì»ý¹°, ½Ä¹°, µ¿¹°ÀÇ ¼¼Æ÷¸·°ú ¿±·Ïü, ¹ÌÅäÄܵ帮¾ÆÀÇ ³», ¿Ü¸·, °ñÁöü, ¼ÒÆ÷ü ¸·, ÇÙ¸· µîÀÌ º¸±âÀÌ´Ù. »ýü¸·ÀÇ ±¸Á¶¿¡ °üÇÑ ¸ðµ¨Àº ¿©·¯ °¡Áö°¡ Á¦½ÃµÇ¾úÀ¸³ª °áÁ¤ÀûÀÎ °ÍÀº ¾ø´Ù. ¿ª»çÀûÀ¸·Î º¼ ¶§ J.F. ´Ù´Ï¿¤ ¸®°¡ Á¦Ã¢Çϰí J.D. ·Î¹öÆ®½¼¿¡ ÀÇÇØ ¼öÁ¤µÈ ´ÜÀ§¸· ¸ðµ¨ÀÌ ÀÖÀ¸¸ç, ±× ÈÄ B. º¥¼Õ µî¿¡ ÀÇÇØ Á¦Ã¢µÈ ¹Ýº¹ ´ÜÀ§ ¸ðµ¨ÀÌ ÀÖ´Ù. ÇöÀç ³Î¸® ÀÎÁ¤¹Þ°í ÀÖ´Â °ÍÀ¸·Î´Â 1972³â S.J. ½Ì°Å µîÀÌ Á¦Ã¢ÇÑ À¯µ¿ ¸ðÀÚÀÌÅ© ¸ðµ¨ÀÌ ÀÖ´Ù. ¸·ÀÇ ÁÖ ¼ººÐÀº ´Ü¹éÁú°ú ÁöÁúÀÌ¸ç µÎ ¼ººÐÀÇ Áß·®ºñ´Â 3:2~3:1·Î ´Ü¹éÁúÀÌ ¸¹´Ù. ÁöÁúÀÇ ÁÖ ¼ººÐÀº ÀÎÁöÁúÀÌ¸ç »ýü¸·ÀÇ ¼ººÐÀ¸·Î ´Ù´ç·ùµµ ¾à°£ Á¸ÀçÇÑ´Ù. ¸·ÀÇ ±¸¼º ¼ººÐÀÎ ÀÎÁöÁú ºÐÀÚ´Â ÀϺκп¡ Ä£¼ö¼º±â¸¦ °¡Áø °¡´À´Ù¶õ ºÐÀڷμ­, ±× ±ä ÃàÀÌ ¸·¸é°ú Á÷°¢À¸·Î ´Ã¾î¼­ ÀÖ°í ¼Ò¼ö¼º ºÎºÐÀÌ ¸¶ÁÖº¸°í ÀÖ¾î 2ºÐÀÚ µÎ²²ÀÇ ¸·À» ¸¸µç´Ù. ´Ü¹éÁúÀº ÁÖ·Î ±¸»ó ´Ü¹éÁúÀ̸ç, ÀÌ ÁöÁú ÀÌÁßÃþ ¼Ó¿¡ ´Ü¹éÁúÀÇ ¼Ò¼ö¼º ºÎºÐÀÌ Àá°Ü ÀÖµíÀÌ Á¸ÀçÇÑ´Ù. ¾î¶² °ÍÀº ¸·ÀÇ ¾ç¸é¿¡ ºÐÀÚÀÇ ÀϺκÐÀ» µå·¯³»°í ÀÖ´Ù. ÀÌ °á°ú ¸·Àº ÁöÁú°ú ´Ü¹éÁúÀÌ ¸ðÀÚÀÌÅ© »óÀ¸·Î Á¸ÀçÇÏ´Â ±¸Á¶°¡ µÈ´Ù. ÁöÁúÀº »ý¸®Àû ¿Âµµ¿¡¼­´Â ¾×üÀ̱⠶§¹®¿¡ ¸· ¼ººÐÀÎ ´Ü¹éÁúÀº ºñ±³Àû ÀÚÀ¯·Ó°Ô ¸·³»¸¦ À̵¿
  • bowmans membrane
    ¾Õ°æ°èÆÇ
  • bucconasal membrane
    ±¸ºñ¸·
  • buccopharyngeal membrane
    ÇùÀεΠ¸·
  • cell membrane permeability
    ¼¼Æ÷¸· Åõ°ú¼º
  • cellular membrane
    ¼¼Æ÷¼º ¸·
    ¼¼Æ÷ÀÇ Ç¥¸éÀ» µ¤°Å³ª °øµ¿ÀÇ ³»¸éÀ» µ¤´Â, ¶Ç´Â °ø°£À̳ª ±â°üÀ» ³ª´©´Â ¾ãÀº ÃþÀÇ Á¶Á÷.
  • cellulose membrane
    ¼¿·ê·Î½º ¸·
  • chorioallantoic membrane inoculation
    À¶¸ð ¿ä¸· Á¢Á¾
  • circulating antibasement membrane antibody
    ¼øÈ¯ Ç×±âÀú¸· Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
membrane glycoproteins Glycoproteins found on the membrane or surface of cells.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
lysosome associated membrane glycoprotein <protein> Lysosome specific integral membrane glycoproteins. Long luminal domain, short transmembrane domain, very short cytoplasmic tail. Function not yet clear.
(18 Nov 1997)
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins
Registry number: EC 2.4.1.147
Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase
(26 Jun 1999)
amyloidogenic glycoprotein <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome.
See: amyloid precursor protein.
(18 Nov 1997)
b2-glycoprotein II <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings
Registry number: EC 2.4.1.146
Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase
(26 Jun 1999)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b
Registry number: EC 2.4.1.102
Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t
(26 Jun 1999)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides
Registry number: EC 2.4.1.144
Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III
(26 Jun 1999)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
variable surface glycoprotein <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection.
(09 Oct 1997)
mannosyl-glycoprotein endo-beta-n-acetylglucosaminidase <enzyme> A group of related enzymes responsible for the endohydrolysis of the di-n-acetylchitobiosyl unit in high-mannose-content glycopeptides and glycoproteins.
Chemical name: Glycopeptide-D-mannosyl-N(4)-(N-acetyl-D-glucosaminyl)2-asparagine 1,4-N-acetyl-beta-glucosaminohydrolase
Registry number: EC 3.2.1.96
(12 Dec 1998)
glycine-rich beta-glycoprotein <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
glycoprotein <protein> Proteins with covalently attached sugar units, either bonded via the OH group of serine or threonine O glycosylated) or through the amide NH2 of asparagine (N glycosylated).
Includes most secreted proteins (serum albumin is the major exception) and proteins exposed at the outer surface of the plasma membrane. Sugar residues found include: mannose, N acetyl glucosamine, N acetyl galactosamine, galactose, fucose and sialic acid.
(18 Nov 1997)
glycoprotein endo-alpha-1,3-mannosidase <enzyme> An endomannosidase; cleaves glucosyl alpha1-3-mannose from monoglucosylated oligosaccharide (glcman(7-9)glcnac) of the glycoprotein produced in the golgi membrane
Registry number: EC 3.2.1.130
Synonym: glucosyl mannosidase
(26 Jun 1999)
glycoprotein glycosyltransferase <enzyme> Enzymes which add monosaccharides from nucleoside mono-or diphosphate monosaccharides onto glycoproteins
Registry number: EC 2.4.1.-
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Membrane Glycoproteins - »õâ Glycoproteins found on the membrane or surface of cells.
    Synonyms : Cell Surface Glycoprotein, Membrane Glycoprotein, Surface Glycoprotein, Glycoprotein, Cell Surface, Glycoprotein, Membrane, Glycoprotein, Surface, Glycoproteins, Cell Surface, Glycoproteins, Membrane, Glycoproteins, Surface, Surface Glycoprotein, Cell
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycoprotein
    ´ç´Ü¹é(Áú)(Á¡¾×¼Ò ¹× ¿¬°ñÀÇ ÁÖ¼ººÐ)
  • cell membrane
    ¼¼Æ÷¸·;¿øÇüÁú¸·;=CELL WALL
  • membrane
    ¾ãÀº ¸·;¸·ÇÇ;¾çÇÇÁö;¹®¼­ÀÇ ÇÑÀå
  • mucous membrane
    Á¡¸·
  • nictitating membrane
    ¼ø¸·;(»õ ¾Ç¾îµîÀÇ ´«²¨Ç® ¾ÈÂÊ¿¡ ÀÖ´Â Á¦ 3ÀÇ ´«²¨Ç®)
  • nuclear membrane
    (»ý)ÇÙ¸·
  • tympanic membrane
    °í¸·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á